Blood transcriptomic biomarkers for tuberculosis screening: time to redefine our target populations?

Lancet Glob Health. 2021 Jun;9(6):e736-e737. doi: 10.1016/S2214-109X(21)00088-7. Epub 2021 Apr 13.

Authors

Rishi Kumar Gupta¹, Mahdad Noursadeghi²

Affiliations

¹ Institute for Global Health, University College London, London WC1E 6JB, UK. Electronic address: r.gupta@ucl.ac.uk.
² Division of Infection and Immunity, University College London, London WC1E 6JB, UK.

PMID: 33862011
DOI: 10.1016/S2214-109X(21)00088-7

No abstract available

MeSH terms

Biomarkers / blood
Health Services Needs and Demand
Humans
Mass Screening / methods*
Transcriptome*
Tuberculosis / blood
Tuberculosis / diagnosis*

Substances

Biomarkers

Grants and funding

207511/Z/17/Z/WT_/Wellcome Trust/United Kingdom